Advertisement

Topics

‘Unrealistic’ serialization deadline? FDA offers one year grace period

11:23 EDT 4 Jul 2017 | in-PharmaTechnologis

The US Food and Drug Administration (FDA) has released draft guidelines offering a reprieve for manufacturers which have not integrated product identifier requirements by the November 26 serialisation deadline.

Original Article: ‘Unrealistic’ serialization deadline? FDA offers one year grace period

NEXT ARTICLE

More From BioPortfolio on "‘Unrealistic’ serialization deadline? FDA offers one year grace period"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...